- Release Date: 28/10/22 08:09
- Summary: ResMed Announces Results for the First Quarter of FY2023
- Price Sensitive: Yes
- Download Document 136.42KB
- Forums
- ASX - By Stock
- RMD
- Ann: ResMed Announces Results for the First Quarter of FY2023
Ann: ResMed Announces Results for the First Quarter of FY2023
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$37.49 |
Change
-0.665(1.74%) |
Mkt cap ! $22.90B |
Open | High | Low | Value | Volume |
$37.62 | $37.82 | $37.39 | $10.15M | 270.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 563 | $37.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$37.49 | 321 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 309 | 37.470 |
6 | 469 | 37.460 |
5 | 468 | 37.450 |
3 | 279 | 37.440 |
3 | 288 | 37.430 |
Price($) | Vol. | No. |
---|---|---|
37.490 | 128 | 3 |
37.500 | 711 | 6 |
37.510 | 213 | 2 |
37.520 | 237 | 3 |
37.530 | 5205 | 4 |
Last trade - 14.26pm 13/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online